Companies: 10,795·Total market cap: $144.5T

Structure Therapeutics Inc.

Structure Therapeutics Inc.

GPCRNASDAQHealthcare● Active

$37.52

$-0.06(-0.16%)

Market Cap$2.2B

P/E Ratio—

52W High$94.9

52W Low$15.8

Avg Volume897K

Open$37.47

Beta-1.42

股票排行：Biotechnology·Healthcare·查看全部市值排行 →

Structure Therapeutics Inc.（GPCR）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · GPCR · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-2.64Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)0.00Full revenue history

Dividend Yield不分红Dividend history

Shares Outstanding59.2MShares outstanding history

Next EarningsAug 6, 2026Est.Earnings history

探索 Structure Therapeutics Inc. 数据

分析师预测$115 · Buy

股息不分红

盈利EPS $-2.40-2.56%

财务快照

FY 2025Revenue$0.00

202320242025

FY 2025Net Income-$141.2M▼ 15.24% YoY

202320242025

FY 2025EPS$-2.40▼ 2.56% YoY

202320242025

TTM:Revenue: $0.00Net Income: -$170.6MEPS: $-2.64View income statement →

分析师评级与目标价

Buy14 位分析师

Strong Buy

0

Buy

14

Hold

0

Sell

0

Strong Sell

0

12-Month Price Target

$90.00Low

$37.52Current

$114.75Avg Target上涨空间 205.84%

$145.00High

合计: 14 · 买入占比: 100.0%

根据过去 3 个月内 14 位华尔街分析师，GPCR 共识评级为 Buy，12 个月平均目标价 $114.75 （较现价 $37.52 上涨空间 205.84%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Structure Therapeutics Inc.

$37.52-0.16%$2.2B #2

AbCellera Biologics Inc.

$5.62+0.18%$1.7B #3

Celldex Therapeutics, Inc.

$28.55-0.21%$1.9B #4

Edgewise Therapeutics, Inc.

$35.62-4.41%$3.8B #5

$27.98+1.71%$1.8B #6

Liquidia Corporation

$64.32+5.77%$5.7B

股票表现

1D-0.16%

1W+0.32%

1M-4.04%

3M-35.01%

YTD-46.05%

1Y+82.94%

5Y+44.31%

关于 Structure Therapeutics Inc.

CEORaymond C. Stevens

IPO DateFeb 3, 2023

Employees163

CountryUS

Websitestructuretx.com

Structure Therapeutics Inc. a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic diseases with unmet medical needs. Its lead pr…

Biotechnology HealthcareNASDAQADRUS

关于股票概览与关键数据

Structure Therapeutics Inc.（GPCR）是 Biotechnology 行业的 Healthcare 类公司，于 Feb 3, 2023 在 NASDAQ 上市。截至最近交易日，GPCR 股价为 $37.52，市值约为 $2.2B。过去12个月累计回报 +82.94%，年初至今回报 -46.05%。

根据 14 位华尔街分析师，Structure Therapeutics Inc. 股票共识评级为Buy，12个月平均目标价为 $114.75。2025 财年 Structure Therapeutics Inc. 营收 —，净利润 -$141.2M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Structure Therapeutics Inc.（GPCR）股价为 $37.52，在 NASDAQ 上市，52周区间为 $15.80 – $94.90。

GPCR 最新股价GPCR quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议